title: [Chronic suppurative canaliculitis - clinical and therapeutic aspects: report of 3 cases].
abstract: Lacrimal canaliculitis is a rare disease caused mainly by Actinomyces israelii. It should be regarded as a differential diagnosis of recurrent chronic conjunctivitis. The purpose of this study was to report 3 cases of chronic suppurative canaliculitis and different treatment options. The first patient presented with an upper left canaliculitis and was treated with a canaliculotomy. Nevertheless, he had an ipsilateral lower canaliculitis after 6 months and underwent intracanalicular injections of fortified cefazolin with complete remission. The second patient presented with a lower left canaliculitis and underwent a canaliculotomy. The third patient had a lower left canaliculitis and underwent intracanalicular injections of fortified cefazolin. Both achieved complete remission. The present article demonstrated that intracanalicular irrigation of fortified cefazolin may be a helpful treatment of chronic suppurative canaliculitis with mild symptoms and signs. The most important benefit of this approach is to avoid injury to the lacrimal canaliculus.
authors.affiliation: Curso de Aperfeiçoamento da Seção de Orbita, Oculoplástica e Vias Lacrimais, Hospital Central, Irmandade Santa Casa de Misericórdia de São Paulo - São Paulo (SP), Brazil. fernandamarcio@hotmail.com
authors.forename: Fernanda
authors.initials: F
authors.lastname: Marcio
authors.forename: Renato Wendell
authors.initials: RW
authors.lastname: Damasceno
authors.forename: Fausto da Paz
authors.initials: Fda P
authors.lastname: Cazorla
authors.forename: Simone Haber Duellberg
authors.initials: SH
authors.lastname: Von Faber Bison
authors.forename: José
authors.initials: J
authors.lastname: Vital Filho
mesh_terms: D000190:Actinomyces / Q000201:enzymology; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002437:Cefazolin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003607:Dacryocystitis / Q000382:microbiology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000900:Anti-Bacterial Agents; D002437:Cefazolin